Core Viewpoint - The animal health sector experienced a significant decline of 4.0% on November 21, with Shunlian Biological leading the drop [1] Market Performance - The Shanghai Composite Index closed at 3834.89, down 2.45% - The Shenzhen Component Index closed at 12538.07, down 3.41% [1] Individual Stock Performance - Shunlian Biological (688098) closed at 9.33, down 5.85% with a trading volume of 58,100 shares and a turnover of 55.30 million yuan - Huisheng Biological (300871) closed at 19.33, down 5.71% with a trading volume of 65,400 shares and a turnover of 130 million yuan - Yongshun Biological (920729) closed at 8.81, down 5.47% with a trading volume of 23,700 shares and a turnover of 21.71 million yuan - *ST Green Health (002868) closed at 41.88, down 4.99% with a trading volume of 5,569 shares and a turnover of 23.32 million yuan - Biological Shares (600201) closed at 11.76, down 4.85% with a trading volume of 491,800 shares [1] Capital Flow Analysis - The animal health sector saw a net outflow of 128 million yuan from institutional investors, while retail investors had a net inflow of 87.82 million yuan [1] - The following stocks had notable capital flows: - Shunlian Biological: net outflow of 11.71 million yuan from institutional investors [2] - *ST Green Health: net outflow of 6.34 million yuan from institutional investors, but a net inflow of 990,000 yuan from retail investors [2] - Huisheng Biological: net outflow of 8.69 million yuan from institutional investors, with a net inflow of 432,630 yuan from retail investors [2]

公司控股股东及本公司董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 绿康生化股份有限公司（以下简称"公司"或"绿康生化"）于 2025 年 11 月 20 日收到控股股东上海康怡投资有限公司（以下简称"上海康怡"）的通知，获悉其所持 有的本公司部分股票办理了解除质押业务，具体事项如下： 证券代码：002868 证券简称：绿康生化 公告编号：2025-123 绿康生化股份有限公司 关于控股股东部分股票解除质押的公告 注：上表中"未质押股份限售和冻结数量"的限售部分为高管锁定股数量；本公告中所涉数据 的尾数差异或不符系四舍五入所致。 3. 其他情况说明 截至本公告披露日，公司控股股东所质押股份不存在平仓风险或被强制过户的情形， 不会对公司生产经营、公司治理等产生实质性影响。公司将持续关注其质押变动情况， 并按照有关规定及时履行信息披露义务。 一、股东股份质押的基本情况 1. 本次股东股份解除质押基本情况 | 股东 | 是否为控股 股东或第一 | | 本次解除 质押股份 | 占其所持 | 占公司总 | 起始日 | 解除日期 | 质权人 | | --- | --- | --- ...

证券代码：002868 证券简称：*ST 绿康 公告编号：2025-124 绿康生化股份有限公司 关于召开 2025 年第四次临时股东会的提示性 公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要提示： 绿康生化股份有限公司（以下简称"公司"或"绿康生化"）于 2025 年 11 月 5 日召开的第五届董事会第二十四次（临时）会议审议通过了《关于召开 2025 年第四次临时股东会的议案》，决定于 2025 年 11 月 24 日 15:00 召开公 司 2025 年第四次临时股东会。具体内容详见公司于 2025 年 11 月 7 日在《证券 日报》和巨潮资讯网（http://www.cninfo.com.cn）披露的《关于召开 2025 年第 四次临时股东会的通知》（公告编号：2025-114）。 公司于 2025 年 11 月 13 日召开第五届董事会第二十五次（临时）会议，审 议通过了《关于补选公司独立董事的议案》，该项议案尚需提交公司股东会审 议。鉴于前述议案亦需提交股东会审议且公司已定于 2025 年 11 月 24 日召开 2025 年第四次 ...

Core Viewpoint - The announcement from Green康生化 indicates that its controlling shareholder, Shanghai康怡, has released a portion of its pledged shares, which does not pose any substantial risk to the company [1] Group 1: Share Pledge Details - On November 20, 2025, the controlling shareholder Shanghai康怡 notified that 5.1352 million shares were released from pledge on November 19, accounting for 10.86% of its holdings and 3.30% of the company's total share capital [1] - As of the announcement date, Shanghai康怡 and its concerted parties have a total of 5.2 million shares pledged, representing 10.61% of their holdings and 3.35% of the company's total share capital [1] Group 2: Risk Assessment - There is no risk of forced liquidation or transfer of the pledged shares from the controlling shareholder, indicating stability for the company [1]

Market Overview - On November 20, A-shares experienced significant fluctuations, with the Shanghai Composite Index closing down by 0.4%, the Shenzhen Component Index down by 0.76%, and the ChiNext Index down by 1.12% [1][2] - The total market turnover exceeded 1.7 trillion yuan, with over 3,800 stocks declining [2] Stock Performance - The banking sector showed resilience, with China Bank and Industrial and Commercial Bank reaching new highs [2] - The Hainan Free Trade Zone sector surged, with Hainan Haiyao hitting the daily limit [2] - The lithium extraction sector also saw gains, with companies like Beijiete and Zhengguang shares hitting the daily limit of 20% [2] - Conversely, sectors such as coal, prepared dishes, dairy, and organic silicon experienced declines [2] Company Specifics - Heff China resumed trading and hit the daily limit, closing at 26.18 yuan per share after a significant rise of 291.92% over 15 trading days prior to November 17 [3][5] - Heff China's main business includes AI-assisted clinical diagnosis systems, remote medical services, and management of medical resources [5] - The stock of Heff China was suspended for trading due to abnormal fluctuations, but no additional favorable information was disclosed upon resumption [5] Notable Stock Movements - The stock of Renmin Tongtai faced a consecutive drop, hitting the limit down after a previous six-day surge of 88.71% [6][8] - ST Lvkang also experienced a "heaven and earth board" phenomenon, with significant volatility following a nine-day rise [8] - Jiumuwang exhibited extreme volatility, opening at the limit up, then hitting the limit down, before recovering to the limit up again, with a cumulative increase of 99.46% in November [10][12]

Group 1: New Stock Offerings - Tianpu Co., Ltd. (Stock Code: 605255) has a tender offer period from November 20, 2025, to December 19, 2025[1] - Hangzhou Steam Turbine Co., Ltd. (Stock Code: 200771) has a cash option declaration period from November 19, 2025, to November 25, 2025[1] - Central Plaza (Stock Code: 600280) announced on November 20, 2025[1] Group 2: Stock Performance Alerts - Moen Electric (Stock Code: 002451) reported severe abnormal fluctuations on November 14, 2025[1] - ST Yuancheng (Stock Code: 603388) reported severe abnormal fluctuations on November 11, 2025[1] - ST Keli Da (Stock Code: 603828) reported severe abnormal fluctuations on November 12, 2025[1] Group 3: Recent Announcements - Jiumuwang (Stock Code: 601566) announced on November 20, 2025[1] - Taiping Bird (Stock Code: 603877) announced on November 20, 2025[1] - Huaci Co., Ltd. (Stock Code: 001216) announced on November 20, 2025[1]

证券代码：002868 证券简称：*ST 绿康 公告编号：2025-122 绿康生化股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露真实、准确、完整，没有虚假记 载、误导性陈述或者重大遗漏 特别提示： 1、鉴于绿康生化股份有限公司（以下简称"公司"）2024 年经审计期末净 资产为-2,453.61 元，公司股票已被实施"退市风险警示"。此外，公司最近连续 三个会计年度（2022 年、2023 年、2024 年）扣除非经常性损益前后净利润均为 负值，且 2024 年被出具"与持续经营相关的重大不确定性部分"的审计意见， 公司股票被叠加实施"其他风险警示"。 2、公司 2025 年前三季度营业收入为 40,967.34 万元，归属于上市公司股东 的净利润为-8,258.85 万元；归属于上市公司股东的扣除非经常性损益的净利润为 -9,163.06 万元。截至 2025 年 9 月 30 日，公司归属于上市公司股东的所有者权益 为-10,638.20 万元，仍为负数。若公司 2025 年度经审计的期末净资产为负值，根 据《深圳证券交易所股票上市规则》9.3.12 相关规定，公司将被终止上市。 ...

Core Insights - The animal health sector experienced a decline of 0.24% on November 17, with Dayu Biological leading the drop [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Stock Performance - Notable gainers included: - Qudongli (code: 920275) with a closing price of 10.68, up 5.12% [1] - *ST Lvkang (code: 002868) with a closing price of 42.57, up 5.01% [1] - Houfeng Holdings (code: 002141) with a closing price of 3.91, up 2.62% [1] - Major decliners included: - Dayu Biological (code: 920970) with a closing price of 8.70, down 3.87% [2] - Ruipu Biological (code: 300119) with a closing price of 20.61, down 2.92% [2] - Zhongmu Co., Ltd. (code: 600195) with a closing price of 7.94, down 1.98% [2] Capital Flow - The animal health sector saw a net outflow of 10.15 million yuan from institutional investors, while retail investors experienced a net outflow of 20.76 million yuan [2] - Conversely, speculative funds recorded a net inflow of 30.91 million yuan [2] Individual Stock Capital Flow - Notable capital flows included: - Biological Shares (code: 600201) with a net inflow of 12.08 million yuan from institutional investors [3] - Xianfeng Holdings (code: 002141) with a net inflow of 9.50 million yuan from institutional investors [3] - Ruipu Biological (code: 300119) with a net inflow of 1.05 million yuan from speculative funds [3] - Decliners in capital flow included: - *ST Lvkang (code: 002868) with a net outflow of 0.79 million yuan from institutional investors [3] - Hai Li Biological (code: 603718) with a net outflow of 2.82 million yuan from institutional investors [3]

Core Viewpoint - *ST Green Health has completed the release of the 100% equity pledge of its wholly-owned subsidiary, Green Health (Yushan) Film Material Co., Ltd., which was previously pledged as collateral for a 160 million yuan acquisition loan [1][2][4] Group 1: Background of the Event - The equity pledge was originally established to secure a 160 million yuan acquisition loan approved by the board on February 21, 2023 [2] - The loan was arranged with China CITIC Bank and was crucial for ensuring the acquisition funding was in place [2] Group 2: Release of Pledge - The company has optimized its collateral structure by replacing the equity pledge with a mortgage on the subsidiary's own assets [3] - Following the completion of the asset mortgage procedures, the company proceeded to release the equity pledge [3] Group 3: Impact of the Event - The release of the equity pledge restores the 100% equity of Green Health (Yushan) to an unencumbered state, enhancing the flexibility for future operations and capital movements [4] - This change reduces the potential risk of the parent company's equity being pledged, thereby strengthening the company's asset structure [4] - The company stated that this release of the equity pledge will not adversely affect its daily operations [4]

证券代码：002868 证券简称：*ST 绿康 公告编号：2025-121 绿康生化股份有限公司 针对上述借款及股权质押事宜，根据公司发展规划需要，上述事项以绿康玉 山自有资产抵押担保的方式向中信银行办理相关手续，绿康玉山自有资产抵押担 保手续办理完成后，公司办理了对绿康玉山100%股权的解除质押手续。详见2025 年 11 月 07 日在《证券日报》和巨潮资讯网（http://www.cninfo.com.cn）披露的 《关于公司向银行申请授信及担保资产调整的公告》（公告编号：2025-115）。 公司于近日收到玉山县市场监督管理局下发的(饶玉)内资股权登记销字 [2025]67659277 号《股权出质注销登记通知书》，公司持有的绿康玉山 100%股 权已全部解除质押。 1 三、备查文件 《股权出质注销登记通知书》 特此公告。 绿康生化股份有限公司 关于公司子公司股权解除质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、股权质押的基本情况 绿康生化股份有限公司（以下简称"公司"或"绿康生化"）于 2023 年 02 月 21 日召开第四届董事 ...